Ely Benaim's Net Worth
$5.62 Million
Who is Ely Benaim?
Ely Benaim has an estimated net worth of $5.62 Million. This is based on reported shares across multiple companies, which include NovoCure Ltd, and REXAHN PHARMACEUTICALS, INC..
SEC CIK
Ely Benaim's CIK is 0001632237
Past Insider Trading and Trends
2021 was Ely Benaim's most active year for acquiring shares with 10 total transactions. Ely Benaim's most active month to acquire stocks was the month of February. 2021 was Ely Benaim's most active year for disposing of shares, totalling 20 transactions. Ely Benaim's most active month to dispose stocks was the month of April. 2022 saw Ely Benaim paying a total of $2,907,710.30 for 53,522 shares, this is the most they've acquired in one year. In 2021 Ely Benaim cashed out on 37,511 shares for a total of $4,084,595.61, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NovoCure Ltd (NVCR) Snapshot price: $14.915
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.34% | 98 |
$62.31 | $6,105.89 | 28.77K |
Jan 6
| |||
Form 4
| -17.21% | -5.96K |
$73.73 | -$439,327.67 | 28.67K |
Scheduled
|
Aug 3
| ||
Form 4
| -1.25% | -437.00 |
$69.66 | -$30,440.98 | 34.63K |
Aug 2
| |||
Form 4
| +0.64% | 222 |
$59.08 | $13,114.65 | 35.07K |
Jul 5
| |||
Form 4
| -10.77% | -4.21K |
$63.17 | -$265,645.81 | 34.85K |
May 10 - May 11
| |||
Form 4
| +53.40% | 15.06K |
$71.83 | -$166,136.46 | 43.26K |
Mar 3 - Mar 4
| |||
Form 4
| +0.20% | 55 |
$63.82 | $3,509.99 | 28.2K |
Jan 6
| |||
Form 4
| -1.62% | -464.00 |
$150.11 | -$69,651.04 | 28.14K |
Scheduled
|
Aug 3
| ||
Form 4
| -1.84% | -536.00 |
$118.97 | -$129,321.27 | 28.61K |
Scheduled
|
Jul 30 - Aug 2
| ||
Form 4
| +0.31% | 90 |
$137.12 | $12,340.98 | 29.14K |
Jul 6
| |||
Form 4
|
—
|
0
|
$123.78 | -$279,422.52 | 29.05K |
Scheduled
|
May 27
| ||
Form 4
| -6.27% | -1.94K |
$180.48 | -$350,672.64 | 29.05K |
Scheduled
|
May 12
| ||
Form 4
| -6.80% | -2.26K |
$115.97 | -$667,877.89 | 31K |
Scheduled
|
May 10 - May 11
| ||
Form 4
|
—
|
0
|
$132.09 | -$809,202.84 | 33.26K |
Scheduled
|
Apr 13
| ||
Form 4
| -8.07% | -2.92K |
$131.53 | -$383,804.54 | 33.26K |
Scheduled
|
Mar 5
| ||
Form 4
| -2.48% | -1.89K |
$106.77 | -$542,601.70 | 74.24K |
Scheduled
|
Mar 3 - Mar 4
| ||
Form 4
| +29.67% | 8.71K |
—
|
—
| 38.06K |
Mar 2
| |||
Form 4
|
—
|
0
|
$106.82 | -$247,861.86 | 29.36K |
Scheduled
|
Dec 21
| ||
Form 4
| -2.20% | -660.00 |
$76.06 | -$50,199.60 | 29.36K |
Scheduled
|
Aug 3
| ||
Form 4
| -0.05% | -16.00 |
$63.40 | -$9,666.68 | 30.02K |
Jul 7 - Jul 31
| |||
Form 4
| -17.06% | -2.60K |
$64.78 | -$168,104.10 | 12.62K |
Scheduled
|
May 12
| ||
Form 4
| +20.57% | 2.6K |
$63.79 | $165,845.23 | 15.21K |
May 8 - May 11
| |||
Form 4
| +92.30% | 14.41K |
—
|
—
| 30.03K |
Mar 3
| |||
Form 4
| +23.79% | 3K |
—
|
—
| 15.62K |
Jul 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
REXAHN PHARMACEUTICALS, INC. (OCUP) Snapshot price: $2.45
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +100.00% | 2.38K |
—
|
—
| 4.75K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
∞
| 2.38K |
—
|
—
| 2.38K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||